The upstart biotech Moderna has led the world in quickly developing a COVID-19 vaccine candidate, called mRNA-1273. The company was the first to start clinical testing and the first to release early human results.
Moderna executives characterized Monday's results as showing the vaccine is safe and tolerable. But researchers observed severe side effects in several of the first 45 volunteers. Larger trials will start soon that test Moderna's serum in hundreds and thousands of people. But if 1 in 10 people — or a higher proportion — experience a severe side effect, that may raise some doubts about the candidate. 'Crazy hours, short nights': The inside story of how a buzzy biotech upstart developed a potential coronavirus vaccine in record timeThis question is best answered by large-scale trials that can compare a group of vaccinated people to a group given a placebo.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:
Business Business Latest News, Business Business Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Moderna coronavirus vaccine releases first human trial results - Business InsiderBusiness Insider is a fast-growing business site with deep financial, media, tech, and other industry verticals. Launched in 2007, the site is now the largest business news site on the web. It will be the first product they ever got to market. Nothing out of trials. Nothing FDA approved. Nothing sold yet. Just saying we are getting excited about a company that has never made a pharma product for public use. My body my choice I won't take no shot ahmad_shahzwan habisla degree first sem kena face to face... Aku nak online 😭
Source: BusinessInsider - 🏆 729. / 51 Read more »
Asian stocks rise after Moderna's coronavirus vaccine delivers early positive results | Markets InsiderAsian stocks rose on Tuesday after Moderna reported promising results from the first human trials of its coronavirus vaccine. US futures slid af... Grabbing at straws Chennylou 🙏🏾
Source: BusinessInsider - 🏆 729. / 51 Read more »
Stocks rebound as positive Moderna vaccine trial boosts optimism for economic recoveryStocks bounced back Monday on optimism the U.S. economy may start to recover from the coronavirus pandemic after drugmaker Moderna released promising early results for a vaccine. result ?didnt stop the virus ! but didnt kill any rats in the last test
Source: USATODAY - 🏆 100. / 63 Read more »
Promising Early Stage Vaccine Trial Sends Stocks SoaringEight healthy patients who received the vaccine developed antibodies at levels similar to those who’ve recovered from COVID-19. 🙏
Source: NYMag - 🏆 111. / 63 Read more »